Synergistic targeting of CDK4/6 and BCL-2 pathways in estrogen receptor positive breast cancer

被引：1
|
作者：
Whittle, J. R.
Vaillant, F.
Policheni, A. N.
Liu, K.
Pal, B.
Giner, G.
Fernandez, K.
Gray, D. H.
Caldon, C. E.
Smyth, G. K.
Visvader, J. E.
Lindeman, G. J.
机构：
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Garvan Inst Med Res, Sydney, NSW, Australia
[5] Univ New South Wales, Sydney, NSW, Australia
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-PD7-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD7-07
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer
    Whittle, James R.
    Vaillant, Francois
    Surgenor, Elliot
    Policheni, Antonia N.
    Giner, Goknur
    Capaldo, Bianca D.
    Chen, Huei-Rong
    Liu, He K.
    Dekkers, Johanna F.
    Sachs, Norman
    Clevers, Hans
    Fellowes, Andrew
    Green, Thomas
    Xu, Huiling
    Fox, Stephen B.
    Herold, Marco J.
    Smyth, Gordon K.
    Gray, Daniel H. D.
    Visvader, Jane E.
    Lindeman, Geoffrey J.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 4120 - 4134
  • [2] Targeting CDK4/6 pathways and beyond in breast cancer
    Ribnikar, Domen
    Volovat, Simona Ruxandra
    Cardoso, Fatima
    BREAST, 2019, 43 : 8 - 17
  • [3] Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
    Scheidemann, Erin R.
    Shajahan-Haq, Ayesha N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [4] CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective
    Zhou, Fiona H.
    Downton, Teesha
    Freelander, Allegra
    Hurwitz, Joshua
    Caldon, C. Elizabeth
    Lim, Elgene
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [5] CDK4/6 inhibitor-mediatated radiosensitization of estrogen receptor positive breast cancer
    Pesch, Andrea M.
    Hirsh, Nicole
    Chandler, Benjamin C.
    Michmerhuizen, Anna R.
    Ritter, Cassandra L.
    Androsiglio, Marlie
    Wilder-Romans, Kari
    Liu, Meilan
    Gersch, Christina L.
    Larios, Jose M.
    Rae, James M.
    Speers, Corey W.
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Targeting CDK4/6 in breast cancer
    Shanabag, Anusha
    Armand, Jessica
    Son, Eugene
    Yang, Hee Won
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2025, 57 (02): : 312 - 322
  • [7] Overcoming resistance to inhibitors of CDK4/6 and BET in estrogen receptor-positive breast cancer
    Cosin, Marc
    Tian, Tian
    Oliveros, Winona
    Kharenko, Olesya A.
    van der Horst, Edward H.
    Patel, Reena G.
    Calosing, Cyrus
    Campeau, Eric
    Jahagirdar, Ravi
    Lakhotia, Sanjay
    Mele, Marta
    Palafox, Marta
    Arribas, Joaquin
    Oliveira, Mafalda
    Saura, Cristina
    Serra, Violeta
    Peiro, Sandra
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer
    Merino, D.
    Lok, S. W.
    Visvader, J. E.
    Lindeman, G. J.
    ONCOGENE, 2016, 35 (15) : 1877 - 1887
  • [9] Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer
    D Merino
    S W Lok
    J E Visvader
    G J Lindeman
    Oncogene, 2016, 35 : 1877 - 1887
  • [10] Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
    Herrera-Abreu, Maria Teresa
    Palafox, Marta
    Asghar, Uzma
    Rivas, Martin A.
    Cutts, Rosalind J.
    Garcia-Murillas, Isaac
    Pearson, Alex
    Guzman, Marta
    Rodriguez, Olga
    Grueso, Judit
    Bellet, Meritxell
    Cortes, Javier
    Elliott, Richard
    Pancholi, Sunil
    Baselga, Jose
    Dowsett, Mitch
    Martin, Lesley-Ann
    Turner, Nicholas C.
    Serra, Violeta
    CANCER RESEARCH, 2016, 76 (08) : 2301 - 2313
12345